Hence, a combination of inhibitors blocking both pathways could lead to a significant tumor growth reduction together with a decrease in proliferation indexes, including RB1 phosphorylation, E2F1, CCND1, and PCNA expression levels, in the NPC PDX model (Figure 5). Here, RB1 is linked to nasopharyngeal carcinoma.